dNovo Bio
Towards the Cure for Hair Loss
Towards the Cure for Hair Loss
dNovo Bio is a biotechnology startup founded in 2018 in the United States, with a mission encapsulated in its slogan: "Towards the Cure for Hair Loss". The company's groundbreaking approach involves utilizing direct reprogramming technology to address the prevalent issue of hair loss. By leveraging this innovative technology, dNovo Bio can transform skin, blood, or fat into new hair stem cells, offering a potential solution for hair loss attributed to aging. Recently, the company secured a significant milestone with a $2.70M Seed Round investment on 24 January 2022, drawing support from a notable group of investors including Soma Capital, Felicis Ventures, Y Combinator, Pioneer Fund, Ataria, Justin Mateen, Paul Buchheit, Joey Krug, Jason Hodges, and Jean Pigozzi. Positioned at the intersection of the biotechnology and healthcare industries, dNovo Bio exemplifies the potential for impactful innovation in a prominent and pressing global health concern.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $2.70M | 10 |
|
24 Jan 2022 |
| Seed Round | Unknown | - | 01 Jan 2018 |
No recent news or press coverage available for dNovo Bio.
We care about your data, and we'd love to use cookies make your experience better.
